Company
Headquarters: Paris, France
Employees: 47
CEO: Mr. Michel Finance
€51.6 Million
EUR as of July 1, 2024
US$55.4 Million
Company | Market Cap (USD) |
---|---|
Abbott | $178.02 B |
Stryker Corporation | $126.48 B |
Boston Scientific Corporation | $112.32 B |
Medtronic | $98.95 B |
Edwards Lifesciences Corporation | $55.63 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Affluent Medical SA, a medical devices company, designs, develops, manufactures, and markets implantable prostheses devices in France. The company develops Kardiozis prosthesis for the noninvasive treatment of abdominal aortic aneurysm; Kalios and Epygon implants for the treatment of mitral insufficiency; and Artus implant, an artificial electromechanical implantable sphincter for severe urinary incontinence in women and men. The company was founded in 2011 and is headquartered in Aix-en-Provence, France.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Affluent Medical SA has the following listings and related stock indices.
Stock: Euronext: AFME wb_incandescent
Stock: FSX: 0JZ wb_incandescent